Novo Nordisk A/S
Novo Nordisk is an ESG governance and transparency frontrunner — first CSRD-compliant filer with 152-page ESRS sustainability statement, CDP A List, 25% STIP weight on sustainability (CEO demonstrably penalised), and ISO 14001 across all production facilities. Operational programmes include Suppliers for Zero (1,800+ committed to RE), Maersk cold chain partnership, ReMed device take-back, and Kalundborg biogas industrial symbiosis. Downgraded from Platinum due to absence of green bonds despite Aa3/AA ratings, VP-level sustainability lead (not C-suite), and emissions expected to grow until ~2030 as GLP-1 capacity expansion outpaces decarbonisation.
Technical assessment based on primary disclosures
Primary Data Source
Assurance Verification
Benchmarking Confidence
Pillar Performance
Assessment
Pillar Performance
Governance Chassis
Data Infrastructure
Financial Controls
Operational Linkage
Risk Radar
Assurance Depth
Transparency & Disclosure
Index Disclaimer
RECI public scores are benchmark indicators derived from our interpretation of publicly available evidence at the time of review. They are not credit ratings, ESG ratings, certifications, or assurance statements. Scores reflect the four-stage governance process: AI analyst draft, senior ESG practitioner review, final record approval, and management calibration.